Beam Therapeutics Inc (NASDAQ:BEAM)

Delayed Data
As of May 26
 +0.16 / +0.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 66.00, with a high estimate of 105.00 and a low estimate of 37.00. The median estimate represents a +103.89% increase from the last price of 32.37.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Beam Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.09%
Growthannually -33.61%


Growthquarterly -28.45%
Growthannually 22.16%
Key to the earnings and sales forecast charts.